Brian P. Skorney
PersonHeard in 1 episode across 1 show since Oct 2026
Brian P. Skorney is a senior research analyst at Baird who covers the biotechnology sector. He is known for biotechnology equity research and stock analysis.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Brian P. Skorney comes up on a podcast
One email a week at most, with the new episodes that mention Brian P. Skorney. Free, no account needed, unsubscribe in one click.
What Brian P. Skorney has said on podcasts
8 statements
Biotech degrossing can create a cycle of worsening fund performance.
“it becomes a cycle of sort of everyone seeing performance kind of get hit from, you know, the start of a degrossing.”
Open the episode · Episode 199 - October 16, 2026Listen at 8:03
Hedge-fund degrossing pressure began in early summer.
“that pressure's kind of been on since early summer.”
Open the episode · Episode 199 - October 16, 2026Listen at 9:58
Biotech is far from being in a bubble.
“I think we're very far from a bubble.”
Open the episode · Episode 199 - October 16, 2026Listen at 17:11
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Brian P. Skorney, newest first
